Skip to Main Content
Capabilities / Life Sciences

Life Sciences

Smart legal solutions that protect our clients' developments and discoveries in life sciences.

The Husch Blackwell law firm advises life sciences companies of all sizes, from startups to large investors, on strategies for developing, protecting and commercializing business assets. Our life sciences attorneys provide smart guidance throughout the life cycle of new developments and discoveries, from business formation and financing through marketing and exit planning.

Clients trust our life sciences team, which includes scientists with university and industrial research experience, to understand their unique business needs. Deep industry knowledge informs our counsel on critical  matters as diverse as regulatory compliance; distribution and licensing agreements; litigation; tax planning; mergers, acquisitions and joint ventures; private and public offerings; risk mitigation; and intellectual property.

News Releases | January 17, 2023
Rob Kukuljan Joins Husch Blackwell in Minneapolis
News Releases | November 07, 2022
Husch Blackwell Elects 29 to 2023 New Partner Class
News Releases | September 07, 2022
Husch Blackwell Expands Healthcare and Corporate Law Teams in California

Ericka Curls Bartling will join Husch Blackwell as a partner in the firm’s San Francisco Bay Area office, and Andrew J. Demetriou will join the firm’s Los Angeles office as senior counsel, bolstering the firm’s capabilities and presence in California.

News Releases | April 01, 2022
Husch Blackwell Adds Two Healthcare Partners to Virtual Office

Husch Blackwell is pleased to announce that Lisa T. Thomas and Bryan Stewart have joined the firm’s Healthcare, Life Sciences & Education industry group as partners.

News Releases | December 06, 2021
Husch Blackwell Elects 36 to 2022 Partnership Class
News Releases | October 25, 2021
Husch Blackwell Lands Leading Litigator Tracy Wolf

Tracy Wolf joins Husch Blackwell’s Dallas office as a partner in its Labor & Employment practice team and Healthcare, Life Sciences & Education business unit.

News Releases | October 15, 2021
Husch Blackwell Scores Victory for Sigmapharm in Hatch-Waxman Litigation

Husch Blackwell successfully defended Sigmapharm Laboratories, LLC in connection with its application for approval of a generic version of the antidepressant vortioxetine.

News Releases | December 18, 2020
Husch Blackwell Elects 23 to 2021 Partnership Class

Women comprise 57 percent of the 2021 partnership class.

News Releases | August 18, 2020
Jenna Brofsky to Receive 2020 Missouri Lawyers Media Up & Coming Award

Brofsky was part of a team that in June launched a tool to help small and mid-market businesses return to their worksites during COVID-19 by developing Return-to-Work policies that comply with applicable local, state and federal laws and regulations.

The Husch Blackwell attorneys were fierce and tireless advocates for Virtus. In the face of aggressive actions by our competitors and FDA regulators, they developed and executed a legal plan that protected an important market for us. They have my gratitude and highest recommendation.

Tina Guilder, CEO, Virtus Pharmaceuticals